Bleeding Disorder Testing Global Market Report 2025
상품코드:1702965
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 200 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
출혈성 질환 검사 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.9%의 연평균 복합 성장률(CAGR)로 220억 2,000만 달러 규모에 이를 것으로 예측됩니다. 예측 기간 동안의 성장은 혈우병의 유병률 증가, 출혈성 질환의 증상에 대한 인식 증가, 진단 연구에 대한 투자 증가, 세계 헬스케어 지출 증가, 희귀 출혈성 질환의 유병률 증가에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 기술 발전, 인공지능의 통합, 개인 맞춤형 의료, 원격 의료 서비스, 재택 검사 키트 등을 들 수 있습니다.
임상시험 증가는 향후 몇 년 동안 출혈성 질환 검사 시장의 성장을 가속할 것으로 예측됩니다. 임상시험은 인간을 대상으로 새로운 치료법, 치료법, 의약품, 기술의 안전성과 유효성을 평가하기 위한 조사이며, 그 수가 증가하는 추세입니다. 이러한 증가의 배경에는 의학 연구의 발전, 헬스케어 혁신에 대한 투자 증가, 새로운 치료법 및 치료법에 대한 수요 증가가 있습니다. 이러한 임상시험에서 출혈성 질환 검사는 출혈성 질환에 대한 새로운 약물 및 치료법의 효과와 안전성을 평가하고, 응고 이상을 관리 또는 교정하는 능력을 평가하고, 최적의 용량과 효과를 보장하기 위해 환자의 반응을 모니터링하는 데 매우 중요합니다. 예를 들어, 미국 임상시험 등록기관인 ClinicalTrials.gov에 따르면, 2023년 말까지 약 47만 7,228건의 임상시험이 등록되어 2022년의 43만 7,507건보다 증가할 것으로 예상하고 있습니다. 이처럼 임상시험 수 증가가 출혈성 질환 검사 시장의 확대를 견인하고 있습니다.
출혈성 질환 검사 시장의 주요 기업들은 장기적인 솔루션을 제공하고, 유전성 출혈성 질환을 치료하고, 치료 결과를 개선하고, 시장에서의 입지를 확대하기 위해 혈우병 B 유전자 치료와 같은 혁신적인 제품 개발에 주력하고 있습니다. 혈우병 B는 적절한 혈액 응고에 필요한 혈액응고인자 IX의 결핍을 특징으로 하는 출혈성 질환의 일종입니다. 혈우병 B 유전자 치료는 증상의 원인이 되는 근본적인 유전적 결함을 해결함으로써 장기적인 해결을 목표로 하는 새로운 치료법입니다. 예를 들어, 2023년 2월 호주에 본사를 둔 생명공학 기업 CSL Limited는 중증 및 중등도 혈우병 B형 혈우병 치료를 위한 최초이자 유일한 1회용 유전자 치료제인 HEMGENIX에 대해 유럽위원회로부터 조건부 판매 승인(CMA)을 획득했습니다. 이 혁신적인 치료법은 장기적인 효능을 제공하는 것을 목표로 하고 있으며, 정기적인 인자 보충 요법의 필요성을 줄이거나 없애고 혈우병 B 환자의 표준 치료에 큰 변화를 가져올 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 출혈성 질환 검사 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 출혈성 질환 검사 시장 : 성장률 분석
세계의 출혈성 질환 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 출혈성 질환 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 출혈성 질환 검사 전체 시장(TAM)
제6장 시장 세분화
세계의 출혈성 질환 검사 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
시약 및 소모품
기기
세계의 출혈성 질환 검사 시장 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
혈우병 A
혈우병 B
폰빌레브란트병
특발성 혈소판 감소성 자반병
기타 적응증
세계의 출혈성 질환 검사 시장 치료 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
인자 보충 요법
약물 요법
세계의 출혈성 질환 검사 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진료소
진단센터
기타 최종사용자
세계의 출혈성 질환 검사 시장 : 시약 및 소모품 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
응고 시약
혈장 및 혈액 채취용 소모품
지혈 시약
인자 결핍 검사 키트
활성화 부분 트론보프라스틴 시간(APTT) 시약
세계의 출혈성 질환 검사 시장 : 악기 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
응고 분석 장비
혈소판 기능 분석 장비
지혈 검사기기
POC(Point of Care) 검사 장비
자동 혈액 검사 시스템
제7장 지역별/국가별 분석
세계의 출혈성 질환 검사 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 출혈성 질환 검사 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
출혈성 질환 검사 시장 : 경쟁 구도
출혈성 질환 검사 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
Siemens Healthcare GmbH
Baxter International Inc.
CSL Limited
Octapharma AG
HORIBA Ltd.
Haemonetics Corporation
Diagnostica Stago S.A.S.
Sekisui Diagnostics LLC
Helena Laboratories Corporation
LFB Group
Sysmex Inostics GmbH
Medexus Pharmaceuticals Inc.
Precision Biologics Inc.
Corgenix Inc.
Diapharma Group Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
출혈성 질환 검사 시장(2029년) : 새로운 기회를 제공하는 국가
출혈성 질환 검사 시장(2029년) : 새로운 기회를 제공하는 부문
출혈성 질환 검사 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Bleeding disorder testing encompasses a variety of diagnostic methods aimed at assessing the function and composition of blood to detect abnormalities associated with bleeding disorders. These tests evaluate clotting ability, platelet function, and specific deficiencies or dysfunctions of clotting factors.
The primary product categories for bleeding disorder testing are reagents and consumables, as well as instruments. The reagents and consumables segment includes the chemical substances, materials, and disposable items utilized in the diagnosis and analysis of bleeding disorders. This category features test kits, reagents, and other necessary supplies for performing these tests. Common indications for these tests include hemophilia A, hemophilia B, von Willebrand disease, idiopathic thrombocytopenic purpura, among others. Treatments generally involve factor replacement therapy and drug therapy, and the tests are used by various end-users, such as hospitals, clinics, and diagnostic centers.
The bleeding disorder testing market research report is one of a series of new reports from The Business Research Company that provides bleeding disorder testing market statistics, including bleeding disorder testing industry global market size, regional shares, competitors with a bleeding disorder testing market share, detailed bleeding disorder testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bleeding disorder testing industry. This bleeding disorder testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The bleeding disorder testing market size has grown strongly in recent years. It will grow from $14.99 billion in 2024 to $16.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the increasing prevalence of bleeding disorders, increasing investment in research and development, a growing number of specialized clinics, increasing demand for early diagnosis, and a rising number of clinical trials.
The bleeding disorder testing market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the increasing prevalence of hemophilia rising awareness of bleeding disorder symptoms, increasing investment in diagnostic research, rising healthcare spending globally, and rising prevalence of rare bleeding disorders. Major trends in the forecast period include technological advancements, integration of artificial intelligence, personalized medicine, telemedicine services, and home-based testing kits.
The increasing number of clinical trials is anticipated to boost the growth of the bleeding disorder testing market in the coming years. Clinical trials, which are research studies that evaluate the safety and effectiveness of new medical treatments, therapies, medicines, or technologies in humans, are on the rise. This increase is driven by advancements in medical research, growing investment in healthcare innovation, and the rising demand for new treatments and therapies. In these trials, bleeding disorder testing is crucial for assessing the efficacy and safety of new medicines and therapies for bleeding disorders, evaluating their ability to manage or correct clotting abnormalities, and monitoring patient responses to ensure optimal dosing and effectiveness. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, approximately 477,228 clinical trials were registered by the end of 2023, up from 437,507 in 2022. Thus, the growing number of clinical trials is propelling the bleeding disorder testing market's expansion.
Leading companies in the bleeding disorder testing market are focusing on developing innovative products, such as gene therapy for Hemophilia B, to provide long-term solutions, cure genetic bleeding disorders, improve treatment outcomes, and broaden their market presence. Hemophilia B, characterized by a deficiency of clotting factor IX necessary for proper blood coagulation, is a specific type of bleeding disorder. Gene therapy for Hemophilia B is an emerging treatment that aims to offer a long-term solution by addressing the underlying genetic defect causing the condition. For instance, in February 2023, CSL Limited, an Australia-based biotechnology company, received conditional marketing authorization (CMA) from the European Commission for HEMGENIX, the first and only one-time gene therapy for treating severe and moderately severe Hemophilia B. This innovative treatment aims to provide long-lasting efficacy, potentially reducing or eliminating the need for regular factor replacement therapy and significantly altering the standard of care for Hemophilia B patients.
In May 2022, Sema4, a US-based company specializing in genetic testing and data-driven patient insights, acquired GeneDx, LLC for $150 million. This acquisition aims to enhance Sema4's genetic testing capabilities by integrating GeneDx's expertise in genetic diagnostics for rare and inherited disorders, including bleeding disorders. GeneDx LLC, also based in the US, offers testing related to bleeding disorders as part of its comprehensive genetic diagnostic services.
Major companies operating in the bleeding disorder testing market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Siemens Healthcare GmbH, Baxter International Inc., CSL Limited, Octapharma AG, HORIBA Ltd., Haemonetics Corporation, Diagnostica Stago S.A.S., Sekisui Diagnostics LLC, Helena Laboratories Corporation, LFB Group, Sysmex Inostics GmbH, Medexus Pharmaceuticals Inc., Precision Biologics Inc., Corgenix Inc., Diapharma Group Inc., Hyphen BioMed, Hema Biologics LLC
North America was the largest region in the bleeding disorder testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bleeding disorder testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bleeding disorder testing market consists of revenues earned by entities by providing services such as complete blood count (CBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The bleeding disorder testing market also includes sales of coagulation analyzers, platelet aggregation analyzers, blood collection devices, genetic testing kits, and bleeding time test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bleeding Disorder Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bleeding disorder testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bleeding disorder testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bleeding disorder testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Reagents And Consumables; Instruments
2) By Indication: Hemophilia A; Hemophilia B; Von Willebrand Disease; Idiopathic Thrombocytopenic Purpura; Other Indications
3) By Treatment Type: Factor Replacement Therapy; Drug Therapy
4) By End User: Hospitals And Clinics; Diagnostic Centers; Other End Users
Subsegments:
1) By Reagents And Consumables: Coagulation Reagents; Plasma And Blood Collection Consumables; Hemostasis Reagents; Factor Deficiency Assay Kits; Activated Partial Thromboplastin Time (APTT) Reagents
2) By Instruments: Coagulation Analyzers; Platelet Function Analyzers; Hemostasis Testing Instruments; Point-Of-Care Testing Devices; Automated Blood Testing Systems
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited; Novo Nordisk A/S
3. Bleeding Disorder Testing Market Trends And Strategies
4. Bleeding Disorder Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Bleeding Disorder Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Bleeding Disorder Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bleeding Disorder Testing Market Growth Rate Analysis
5.4. Global Bleeding Disorder Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bleeding Disorder Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bleeding Disorder Testing Total Addressable Market (TAM)
6. Bleeding Disorder Testing Market Segmentation
6.1. Global Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Consumables
Instruments
6.2. Global Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hemophilia A
Hemophilia B
Von Willebrand Disease
Idiopathic Thrombocytopenic Purpura
Other Indications
6.3. Global Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Factor Replacement Therapy
Drug Therapy
6.4. Global Bleeding Disorder Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Other End Users
6.5. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coagulation Reagents
Plasma And Blood Collection Consumables
Hemostasis Reagents
Factor Deficiency Assay Kits
Activated Partial Thromboplastin Time (APTT) Reagents
6.6. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coagulation Analyzers
Platelet Function Analyzers
Hemostasis Testing Instruments
Point-Of-Care Testing Devices
Automated Blood Testing Systems
7. Bleeding Disorder Testing Market Regional And Country Analysis
7.1. Global Bleeding Disorder Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bleeding Disorder Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
